Danaher Corporation (DHR)
Quick ratio
| Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 4,615,000 | 1,528,000 | 2,957,000 | 1,993,000 | 2,078,000 | 2,627,000 | 2,374,000 | 7,031,000 | 5,864,000 | 12,277,000 | 8,575,000 | 7,379,000 | 5,995,000 | 5,150,000 | 3,984,000 | 3,717,000 | 2,586,000 | 2,552,000 | 7,322,000 | 6,330,000 |
| Short-term investments | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Receivables | US$ in thousands | 3,913,000 | 3,755,000 | 4,516,000 | 4,314,000 | 4,390,000 | 3,507,000 | 3,298,000 | 3,379,000 | 4,637,000 | 4,201,000 | 4,199,000 | 4,313,000 | 5,064,000 | 4,409,000 | 4,527,000 | 4,407,000 | 5,443,000 | 4,282,000 | 4,197,000 | 4,026,000 |
| Total current liabilities | US$ in thousands | 6,807,000 | 6,324,000 | 6,792,000 | 6,645,000 | 6,798,000 | 7,339,000 | 6,701,000 | 7,778,000 | 8,274,000 | 9,367,000 | 8,404,000 | 8,730,000 | 8,389,000 | 8,002,000 | 7,556,000 | 7,547,000 | 8,140,000 | 7,257,000 | 6,825,000 | 6,824,000 |
| Quick ratio | 1.25 | 0.84 | 1.10 | 0.95 | 0.95 | 0.84 | 0.85 | 1.34 | 1.27 | 1.76 | 1.52 | 1.34 | 1.32 | 1.19 | 1.13 | 1.08 | 0.99 | 0.94 | 1.69 | 1.52 |
December 31, 2025 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($4,615,000K
+ $—K
+ $3,913,000K)
÷ $6,807,000K
= 1.25
Peer comparison
Dec 31, 2025
Company name
Symbol
Quick ratio
Danaher Corporation
DHR
1.25
Agilent Technologies Inc
A
1.40
Thermo Fisher Scientific Inc
TMO
1.25